flutamide has been researched along with finasteride in 106 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 44 (41.51) | 18.2507 |
| 2000's | 31 (29.25) | 29.6817 |
| 2010's | 29 (27.36) | 24.3611 |
| 2020's | 2 (1.89) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Chopra, P; Farquhar, R; Gediya, LK; Guo, Z; Handratta, VD; Kataria, R; Newman, D; Njar, VC; Qiu, Y; Vasaitis, TS | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alvarez-Manrique, B; Bratoeff, E; Cabeza, M; Cortés-Benítez, F; Ramírez-Apan, MT | 1 |
| Lao, K; Sun, J; Wang, C; Wang, Y; Xiang, H; Xiao, H; You, Q | 1 |
| Imperato-McGinley, J; Sanchez, RS; Spencer, JR; Vaughan, ED; Yee, B | 1 |
| Fleshner, NE; Trachtenberg, J | 3 |
| Imperato-McGinley, J; Sanchez, RS; Spencer, JR; Torrado, T; Vaughan, ED | 1 |
| Husmann, DA; McPhaul, MJ | 1 |
| McConnell, JD | 1 |
| Berman, C; Brooks, JR; Nguyen, H; Prahalada, S; Primka, RL; Rasmusson, GH; Slater, EE | 1 |
| Barbolt, TA; Dube, JY; Egy, MA; Frenette, G; Juniewicz, PE; Tremblay, RR | 1 |
| Chen, C; Labrie, F; Li, X; Puy, LA; Simard, J; Singh, SM | 1 |
| Ball, RA; Leder, P; Ornitz, DM; Richie, JP; Tutrone, RF | 1 |
| Gorczynska, E; Handelsman, DJ | 1 |
| Biordi, L; Bologna, M; Festuccia, C; Muzi, P; Vicentini, C | 1 |
| Heston, WD; Huryk, R; Perez, G; Russo, P; Warner, JA | 1 |
| Husmann, DA; Lephart, ED | 1 |
| Akaza, H; Imada, S; Koiso, K; Otani, M | 1 |
| Hib, J; Ponzio, R | 1 |
| Shaw, JC | 1 |
| Andriole, GL; Charlton, ET; Johnson, B; Ornstein, DK; Rao, GS | 1 |
| Fair, WR; Fleshner, NE | 1 |
| di Salle, E; Giudici, D; Zaccheo, T | 1 |
| Akaza, H; Ami, Y; Ideyama, Y; Imada, S; Koiso, K; Takenaka, T | 1 |
| Berlane, K; Brufsky, A; Fontaine-Rothe, P; Jiroutek, M; Kantoff, P; Kaplan, I; Kaufman, D; Rieker, P | 1 |
| Johnson, H; McDermed, JE; Scholz, MC; Strum, SB; Tisman, G | 1 |
| De Fusco, D; Eleftheriou, G; Falsetti, L; Rosina, B | 1 |
| Kaisary, AV; Matveev, VB; Sandhu, SS | 1 |
| Lowe, FC; Staiman, VR | 1 |
| De Fusco, D; Falsetti, L; Rosina, B | 1 |
| Danielpour, D; Lucia, MS; Roberts, AB; Sporn, MB; Stewart, LV | 1 |
| Schmidt, JB | 1 |
| Coscia, EM; Drea, CM; Forger, NG; Frank, LG; Glickman, SE; Licht, P; Weldele, ML | 1 |
| Sinclair, R; Young, R | 1 |
| Andriole, GL; Ornstein, DK; Smith, DS | 1 |
| Diamanti-Kandarakis, E | 1 |
| Bersi, C; Fruzzetti, F; Genazzani, AR; Parrini, D; Ricci, C | 1 |
| Bagnoli, A; Colombo, FM; Flamigni, C; Macrelli, S; Marescalchi, O; Paradisi, R; Ravaioli, B; Venturoli, S | 1 |
| Kellogg, CK; Lundin, A | 1 |
| Andriole, GL; Beiser, JA; Ornstein, DK | 1 |
| Rittmaster, RS | 1 |
| Altwein, J; Boyle, P; Denis, LJ; Griffiths, K; Kirby, R; Robertson, C; Schröder, F; Turkes, A | 1 |
| Falsetti, L; Gambera, A | 1 |
| Andriole, GL; Bhayani, SB | 1 |
| Bugari, G; Falsetti, L; Gambera, A; Iacobello, C; Legrenzi, L | 1 |
| Gilhar, A; Serafimovich, S; Sintov, A | 1 |
| Castello, R; Dorizzi, R; Fortunato, A; Moghetti, P; Muggeo, M; Negri, C; Spiazzi, GG; Tosi, F | 1 |
| Caputo, M; Castello, R; Misciali, C; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Tosti, A | 1 |
| Bayram, F; Güven, M; Müderris, II | 1 |
| Leibowitz, RL; Tucker, SJ | 1 |
| Ashby, J; Deghenghi, R; Lefevre, PA; Wallis, N | 1 |
| Carmina, E; Lobo, RA | 2 |
| Coscia, EM; Drea, CM; Glickman, SE; Holekamp, KE; Place, NJ; Sisk, CL; Weldele, ML | 1 |
| Coscia, EM; Drea, CM; Glickman, SE; Licht, P; Place, NJ; Weldele, ML | 1 |
| Bahnson, R; Bissonette, EA; Miller, NL; Theodorescu, D; Wilson, J | 1 |
| Bittmann, L; Brufsky, A; Kantoff, PW; Kaplan, ID; Kaufman, DS; Manola, J; Oh, WK; Smith, MR | 1 |
| Barqawi, AB; Crawford, ED; Handel, L; Moul, JW; Ziada, A | 1 |
| Fukabori, Y; Honma, S; Kashiwagi, B; Ono, Y; Shibata, Y; Suzuki, K; Yamanaka, H | 1 |
| Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
| Kelestimur, F; Sahin, Y | 1 |
| Cahlon, O; Cesaretti, JA; Kollmeier, MA; Stock, RG; Stone, NN | 1 |
| Chung, K; Dalton, JT; Gao, W; Kearbey, JD; Miller, DD; Nair, VA; Parlow, AF | 1 |
| Al-Inany, H | 2 |
| Baskin, L; Cao, M; Conley, A; Cunha, GR; Cunha, TJ; Glickman, SE; Place, NJ; Wang, YZ; Weldele, M | 1 |
| Asamoto, M; Cho, YM; Shirai, T; Suzuki, S; Takahashi, S; Tang, M | 1 |
| Matthews, PA | 1 |
| Conway, GS; Koulouri, O | 1 |
| Scheinfeld, N | 1 |
| Bañez, LL; Blake, GW; Crawford, ED; McLeod, DG; Moul, JW | 1 |
| Karaca, Z; Kelestimur, F; Ozel, D; Tanriverdi, F; Unluhizarci, K | 1 |
| Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S | 1 |
| Díaz, M; Gómez, T; González-Montelongo, MC; Marín, R; Marrero-Alonso, J | 1 |
| Coscia, EM; Dahl, NJ; Drea, CM; Glickman, SE; Holekamp, KE; Place, NJ; Roser, JF; Sisk, CL; Weldele, ML | 1 |
| Andruszkow, H; Frink, M; Hildebrand, F; Krettek, C; Mommsen, P; Neunaber, C; Zeckey, C | 1 |
| Alberts, DS; Bartels, HG; Bartels, PH; Carmignani, G; DeCensi, A; Decobelli, O; Hurle, R; Maffezzini, M; Mazzucchelli, R; Montironi, R; Puntoni, M | 1 |
| Ahles, T; Gu, L; Halabi, S; Hussain, A; Kaplan, E; Kelly, WK; Monk, JP; Philips, G; Picus, J; Small, EJ; Vogelzang, N | 1 |
| Cvijetić, S; Dodig, S; Jurasović, J; Milković-Kraus, S; Mück-Šeler, D; Mustapić, M; Pašalić, D; Pauković, P; Pavlović, M; Pivac, N; Pizent, A | 1 |
| Campelo, AE; Cutini, PH; Massheimer, VL | 1 |
| Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
| Dehghan, F; Muniandy, S; Salleh, N; Yusof, A | 1 |
| Buzney, C; Buzney, E; Reynolds, RV; Sheu, J | 1 |
| Bechtel, MA; Harfmann, KL | 1 |
| Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
| Ioannides, D; Lazaridou, E | 1 |
| Giribabu, N; Muniandy, S; Ramli, NS; Salleh, N | 1 |
| Fedorowicz, Z; van Zuuren, EJ | 1 |
| Chahal, DS; Hassoun, LA; Larsen, LN; Sivamani, RK | 1 |
| Gholami, K; Giribabu, N; Loh, SY; Salleh, N | 1 |
| Giribabu, N; Khadijah Ramli, NS; Muniandy, S; Salleh, N | 1 |
| Giribabu, N; Khadijah Ramli, NS; Salleh, N | 1 |
| Azarchi, S; Bienenfeld, A; Lo Sicco, K; Marchbein, S; Nagler, AR; Shapiro, J | 1 |
| Giribabu, N; Karim, K; Ramli, NSK; Salleh, N | 1 |
| Faghihi, G; Hoseyni, MS; Iraji, F; Jelvan, M; Saber, M; Siadat, AH | 1 |
| Hsiao, JL; Jeong, C; Masson, R; Shi, VY; Shih, T | 1 |
23 review(s) available for flutamide and finasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Androgen ablation and blockade in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstenes; Azasteroids; Finasteride; Flutamide; Humans; Luteinizing Hormone; Male; Orchiectomy; Prostatic Hyperplasia | 1990 |
Antiandrogen therapy in dermatology.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Cimetidine; Contraceptives, Oral; Cyproterone Acetate; Finasteride; Flutamide; Humans; Ketoconazole; Skin Diseases; Spironolactone | 1996 |
Hirsutes. II: Treatment.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Contraceptives, Oral; Cosmetics; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Hair Removal; Hirsutism; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Prednisolone; Spironolactone | 1998 |
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Topics: Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Humans; Polycystic Ovary Syndrome | 1998 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
Hormonal manipulation for rising PSA after radical prostatectomy.
Topics: Androgen Antagonists; Anilides; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 1999 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
Hormone ablation therapy: lightening the load for today's prostate cancer patient.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Drug Monitoring; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Mass Screening; Neoplasm Staging; Nurse's Role; Nursing Assessment; Oligopeptides; Patient Education as Topic; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Treatment Outcome | 2007 |
A systematic review of commonly used medical treatments for hirsutism in women.
Topics: Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Spironolactone; Thiazolidinediones; Treatment Outcome | 2008 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Anti-androgen treatments.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone | 2010 |
Immunomodulation in polytrauma and polymicrobial sepsis - where do we stand?
Topics: Androstenediol; Animals; Dehydroepiandrosterone; Finasteride; Flutamide; Humans; Immunomodulation; Lipopeptides; Multiple Trauma; Sepsis | 2011 |
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Contraceptives, Oral, Combined; Dermatology; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Life Style; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2014 |
Hair loss in women.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents | 2015 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
The use of hormonal agents in the treatment of acne.
Topics: Acne Vulgaris; Administration, Oral; Contraceptive Agents; Cortodoxone; Cyproterone Acetate; Dermatologic Agents; Female; Finasteride; Flutamide; Hormones; Humans; Male; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Propionates; Spironolactone; Treatment Outcome | 2016 |
Androgens in women: Hormone-modulating therapies for skin disease.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Alopecia; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dutasteride; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Spironolactone | 2019 |
Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
Topics: Finasteride; Flutamide; Hidradenitis Suppurativa; Humans; Liraglutide; Metformin; Spironolactone | 2023 |
24 trial(s) available for flutamide and finasteride
| Article | Year |
|---|---|
Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Testosterone | 1995 |
Combined finasteride and flutamide therapy in men with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms | 1996 |
Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Sexuality; Treatment Failure | 1997 |
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Finasteride; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1997 |
[Finasteride and flutamide in the treatment of hirsutism].
Topics: Administration, Oral; Adult; Androgen Antagonists; Dose-Response Relationship, Drug; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 1997 |
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Failure | 1998 |
Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Hyperandrogenism | 1999 |
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adult; Cyproterone Acetate; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Ketoconazole; Prospective Studies | 1999 |
Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. International Prostate Health Council (IPHC) Trial Study Group.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms | 1999 |
Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstane-3,17-diol; Body Mass Index; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hair; Hirsutism; Humans; Testosterone; Treatment Outcome | 1999 |
Comparison of finasteride versus flutamide in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Polycystic Ovary Syndrome | 1999 |
Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Biomarkers; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Humans; Prostate-Specific Antigen; Spironolactone; Testosterone | 2000 |
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Topics: Adult; Androgen Antagonists; Double-Blind Method; Female; Finasteride; Flutamide; Hair; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 2000 |
A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Body Mass Index; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2000 |
Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2001 |
A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Prospective Studies; Statistics, Nonparametric | 2002 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.
Topics: Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Disease Progression; Drug Resistance, Neoplasm; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 2003 |
Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Survival Analysis; Treatment Outcome | 2003 |
Combined modality treatment in the management of high-risk prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Testosterone | 2004 |
Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Epidemiologic Methods; Finasteride; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2009 |
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry.
Topics: 5-alpha Reductase Inhibitors; Aged; Androgen Antagonists; Cell Nucleus; Cost-Benefit Analysis; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Finasteride; Flutamide; Humans; Karyometry; Male; Middle Aged; Preoperative Period; Prospective Studies; Prostate; Prostatic Neoplasms; Treatment Outcome | 2013 |
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Flutamide; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Failure | 2012 |
Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Topics: Administration, Topical; Alopecia; Finasteride; Flutamide; Humans; Minoxidil; Treatment Outcome | 2022 |
59 other study(ies) available for flutamide and finasteride
| Article | Year |
|---|---|
Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstadienes; Animals; Antineoplastic Agents; Azoles; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Humans; Isoenzymes; Male; Mice; Mice, SCID; Mutation; Prostatic Neoplasms; Pyrazines; Radioligand Assay; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Tissue Distribution; Transcription, Genetic; Transcriptional Activation; Xenograft Model Antitumor Assays | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line.
Topics: Androgens; Androstenes; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Humans; Leukocytes, Mononuclear; Male; Prostatic Neoplasms; Rats | 2016 |
Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Amides; Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Receptors, Androgen; Structure-Activity Relationship | 2017 |
Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Topics: 5-alpha Reductase Inhibitors; Androgen Receptor Antagonists; Androstenes; Animals; Azasteroids; Dose-Response Relationship, Drug; Epididymis; Female; Finasteride; Flutamide; Genitalia, Male; Male; Maternal-Fetal Exchange; Organ Size; Pregnancy; Prostate; Rats; Rats, Inbred Strains; Seminal Vesicles; Sex Differentiation; Testis; Vas Deferens | 1992 |
Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Buserelin; Clusterin; Finasteride; Flutamide; Glycoproteins; Male; Molecular Chaperones; Organ Size; Prostate; Random Allocation; Rats; Rats, Sprague-Dawley; Seminal Vesicles | 1992 |
Effects of flutamide and finasteride on rat testicular descent.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstenes; Animals; Azasteroids; Cryptorchidism; Dihydrotestosterone; Epididymis; Female; Finasteride; Flutamide; Gestational Age; Male; Maternal-Fetal Exchange; Pregnancy; Rats; Rats, Inbred Strains; Testis; Testosterone | 1991 |
Time-specific androgen blockade with flutamide inhibits testicular descent in the rat.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Cryptorchidism; Embryonic and Fetal Development; Female; Finasteride; Flutamide; Male; Maternal-Fetal Exchange; Pregnancy; Rats; Rats, Inbred Strains; Testis | 1991 |
Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenes; Animals; Azasteroids; Diethylstilbestrol; Finasteride; Flutamide; Male; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Inbred F344 | 1991 |
Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenes; Anilides; Animals; Azasteroids; Capsules; Carboxylic Ester Hydrolases; Dogs; Dose-Response Relationship, Drug; Estradiol; Finasteride; Flutamide; Hyperplasia; Injections, Intramuscular; Male; Nitriles; Pregnanes; Prostate; Prostatectomy; Pyrazoles; Tosyl Compounds | 1990 |
Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results.
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Flutamide; Humans; Luteinizing Hormone; Male; Middle Aged; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1993 |
Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Androgen Antagonists; Animals; Cricetinae; Dose-Response Relationship, Drug; Ear; Enzyme Inhibitors; Finasteride; Flutamide; In Situ Hybridization; Male; Mesocricetus; Organ Size; RNA, Messenger; Sebaceous Glands; Thymidine; Tritium | 1995 |
Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Dihydrotestosterone; Disease Models, Animal; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Finasteride; Flutamide; Genes, Viral; Male; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Orchiectomy; Phenotype; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins; Sexual Maturation; Testosterone | 1993 |
Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells.
Topics: Androgen Antagonists; Androgens; Animals; Calcium; Cells, Cultured; Cyclic AMP; Cytosol; Dihydrotestosterone; Drug Synergism; Finasteride; Flutamide; Follicle Stimulating Hormone; Kinetics; Male; Progesterone; Rats; Rats, Wistar; Sertoli Cells; Spermatogenesis; Testosterone; Time Factors | 1995 |
Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro.
Topics: Androgen Antagonists; Cell Division; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Finasteride; Flutamide; Humans; Linear Models; Male; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured | 1995 |
TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
Topics: Animals; Apoptosis; Body Weight; Clusterin; Coumarins; Diethylstilbestrol; Finasteride; Flutamide; Gene Expression Regulation; Genetic Markers; Glycoproteins; Male; Molecular Chaperones; Orchiectomy; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; RNA, Messenger; Testosterone | 1994 |
Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre- and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Animals; Animals, Newborn; Brain Chemistry; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Female; Finasteride; Flutamide; Hypothalamus; Luteinizing Hormone; Male; Pituitary Gland; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 1993 |
[Effects of androgen regulation system on bladder carcinogenesis in male mice].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Butylhydroxybutylnitrosamine; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Leuprolide; Male; Mice; Mice, Inbred C3H; Orchiectomy; Urinary Bladder Neoplasms | 1995 |
The abnormal development of male sex organs in the rat using a pure antiandrogen and a 5 alpha-reductase inhibitor during gestation.
Topics: Androgen Antagonists; Animals; Enzyme Inhibitors; Female; Finasteride; Flutamide; Genitalia, Male; Male; Pregnancy; Prostate; Rats; Rats, Wistar; Sex Differentiation | 1995 |
Anti-androgenic effects of combination finasteride plus flutamide in patients with prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 1996 |
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Leuprolide; Luteinizing Hormone; Male; Organ Size; Pituitary Gland, Anterior; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Seminal Vesicles; Testis; Testosterone | 1997 |
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
Topics: Administration, Oral; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Immunohistochemistry; Leuprolide; Male; Mice; Mice, Inbred C3H; Oxidoreductases; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 1997 |
Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.
Topics: Age Factors; Aged; Anemia; Anilides; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Flutamide; Hemoglobins; Humans; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Testosterone; Time Factors; Tosyl Compounds | 1997 |
Finasteride plus flutamide for prostatic carcinoma.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Male; Prostatic Neoplasms | 1997 |
Tamoxifen for flutamide/finasteride-induced gynecomastia.
Topics: Aged; Androgen Antagonists; Drug Evaluation; Drug Therapy, Combination; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Finasteride; Flutamide; Gynecomastia; Humans; Male; Middle Aged; Prostatic Neoplasms; Tamoxifen; Testosterone; Time Factors | 1997 |
The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Topics: Androgen Antagonists; Androgens; Animals; Antibodies; Cell Division; Cell Line; Dihydrotestosterone; Down-Regulation; Finasteride; Flutamide; Male; Prostate; Rats; Testosterone; Transforming Growth Factor beta | 1998 |
Other antiandrogens.
Topics: Acne Vulgaris; Androgen Antagonists; Cimetidine; Female; Finasteride; Flutamide; Humans; Isotretinoin; Male; Spironolactone | 1998 |
Androgens and masculinization of genitalia in the spotted hyaena (Crocuta crocuta). 2. Effects of prenatal anti-androgens.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstenedione; Animals; Carnivora; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Genitalia; Male; Maternal-Fetal Exchange; Pregnancy; Sex Differentiation; Urogenital System | 1998 |
I've been trying to get rid of excess facial hair ever since I can remember. Is there any effective medication for this problem?
Topics: Androgen Antagonists; Female; Finasteride; Flutamide; Hirsutism; Humans | 1999 |
Brain androgen-inducible aromatase is critical for adolescent organization of environment-specific social interaction in male rats.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adaptation, Physiological; Adaptation, Psychological; Androgen Antagonists; Animals; Aromatase; Aromatase Inhibitors; Body Weight; Brain; Brain Chemistry; Dihydrotestosterone; Enzyme Inhibitors; Fadrozole; Finasteride; Flutamide; Male; Organ Size; Prostate; Rats; Rats, Long-Evans; Receptors, Androgen; Sexual Maturation; Social Dominance; Testosterone | 1999 |
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Finasteride; Flutamide; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1999 |
New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice.
Topics: Administration, Topical; Alopecia; Androgen Antagonists; Animals; Finasteride; Flutamide; Hair Follicle; Humans; Male; Mice; Mice, SCID; Scalp; Skin Absorption; Transplantation, Heterologous | 2000 |
Replacement of surgical castration by GnRH-inhibition or Leydig cell ablation in the male rat Hershberger antiandrogen assay.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Body Weight; Dichlorodiphenyl Dichloroethylene; Dose-Response Relationship, Drug; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormone Replacement Therapy; Insecticides; Leydig Cells; Male; Mesylates; Oligopeptides; Orchiectomy; Organ Size; Rats; Rats, Inbred Strains | 2001 |
Effects of prenatal treatment with antiandrogens on luteinizing hormone secretion and sex steroid concentrations in adult spotted hyenas, Crocuta crocuta.
Topics: Age Factors; Androgen Antagonists; Androgens; Animals; Carnivora; Chorionic Gonadotropin; Female; Finasteride; Flutamide; Genitalia, Female; Genitalia, Male; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Pregnancy; Prenatal Exposure Delayed Effects; Sex Differentiation; Sex Factors; Sexual Maturation; Steroids | 2002 |
Exposure to naturally circulating androgens during foetal life incurs direct reproductive costs in female spotted hyenas, but is prerequisite for male mating.
Topics: Androgen Antagonists; Androgens; Animals; Carnivora; Enzyme Inhibitors; Female; Finasteride; Flutamide; Genitalia, Female; Genitalia, Male; Male; Maternal-Fetal Exchange; Pregnancy; Reproduction; Sex Characteristics; Sexual Behavior, Animal; Species Specificity | 2002 |
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Brachytherapy; Chemotherapy, Adjuvant; Diarrhea; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Logistic Models; Male; Nitriles; Penile Erection; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome; Urinary Incontinence | 2003 |
Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Animals; Capillaries; Chlormadinone Acetate; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Microcirculation; Nitriles; Prazosin; Prostate; Rats; Rats, Wistar; Sulfonamides; Tamsulosin; Testosterone; Tosyl Compounds | 2003 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Animals; Enzyme Inhibitors; Finasteride; Flutamide; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testis | 2004 |
The ontogeny of the urogenital system of the spotted hyena (Crocuta crocuta Erxleben).
Topics: Androgen Antagonists; Animals; Enzyme Inhibitors; Female; Fetus; Finasteride; Flutamide; Genitalia, Female; Genitalia, Male; Hyaenidae; Male; Urinary Tract | 2005 |
Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Animals, Genetically Modified; Antigens, Viral, Tumor; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Flutamide; Male; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone | 2007 |
A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Prospective Studies | 2009 |
Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17.
Topics: Amides; Androgens; Animals; Benzophenanthridines; Blotting, Western; Calcium; Colon; Cycloheximide; Dactinomycin; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; In Vitro Techniques; Male; Mice; Models, Biological; Models, Theoretical; Muscle Contraction; Muscle, Smooth; Phosphorylation; Protein Kinase C; Pyridines; Receptors, Androgen; rho-Associated Kinases; Signal Transduction; Testosterone | 2010 |
The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males.
Topics: Androgen Antagonists; Androstenedione; Animals; Estradiol; Feedback; Female; Finasteride; Flutamide; Hyaenidae; Luteinizing Hormone; Male; Pregnancy; Progesterone; Sex Differentiation; Sex Factors; Testosterone | 2011 |
Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Bone Density; Bone Diseases, Metabolic; Finasteride; Flutamide; Gene Frequency; Genotype; Humans; Male; Pilot Projects; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptor, Serotonin, 5-HT1B; Serotonin | 2012 |
Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
Topics: 5-alpha Reductase Inhibitors; Anastrozole; Androgen Antagonists; Animals; Aorta; Aromatase Inhibitors; Cell Adhesion; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; Estrogen Antagonists; Female; Finasteride; Flutamide; Fulvestrant; Monocytes; Myocytes, Smooth Muscle; Nitric Oxide; Nitriles; Rats; Rats, Wistar; Testosterone; Triazoles | 2012 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Testosterone reduces knee passive range of motion and expression of relaxin receptor isoforms via 5α-dihydrotestosterone and androgen receptor binding.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Animals; Blotting, Western; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Finasteride; Flutamide; Gene Expression; Knee Joint; Ovariectomy; Protein Binding; Range of Motion, Articular; Rats, Inbred WKY; Rats, Wistar; Receptors, Androgen; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; Reverse Transcriptase Polymerase Chain Reaction; Testosterone | 2014 |
Testosterone regulates levels of cystic fibrosis transmembrane regulator, adenylate cyclase, and cAMP in the seminal vesicles of orchidectomized rats.
Topics: 5-alpha Reductase Inhibitors; Adenylate Kinase; Androgen Antagonists; Animals; Bicarbonates; Blotting, Western; Chlorides; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Dihydrotestosterone; Finasteride; Flutamide; Male; Orchiectomy; Rats; Rats, Sprague-Dawley; Semen; Seminal Vesicles; Testosterone | 2016 |
Effects of testosterone on mean arterial pressure and aquaporin (AQP)-1, 2, 3, 4, 6 and 7 expressions in the kidney of orchidectomized, adult male Sprague-Dawley rats.
Topics: Animals; Aquaporins; Blood Pressure; Cohort Studies; Finasteride; Flutamide; Gene Expression Regulation; Kidney Tubules; Kidney Tubules, Collecting; Male; Microscopy, Fluorescence; Orchiectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Testosterone | 2017 |
Testosterone up-regulates vacuolar ATPase expression and functional activities in vas deferens of orchidectomized rats.
Topics: Adenosine Triphosphatases; Androgen Antagonists; Animals; Enzyme Inhibitors; Finasteride; Flutamide; Male; Orchiectomy; Rats; Testosterone; Up-Regulation; Vacuoles; Vas Deferens | 2018 |
Testosterone enhances expression and functional activity of epithelial sodium channel (ENaC), cystic fibrosis transmembrane regulator (CFTR) and sodium hydrogen exchanger (NHE) in vas deferens of sex-steroid deficient male rats.
Topics: Amiloride; Animals; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels; Finasteride; Flutamide; Male; Rats; Sodium-Hydrogen Exchangers; Testosterone; Vas Deferens | 2018 |
Hormonal control of vas deferens fluid volume and aquaporin expression in rats.
Topics: Acetazolamide; Animals; Aquaporins; Body Fluids; Finasteride; Flutamide; Male; Protein Isoforms; Rats; Rats, Sprague-Dawley; Testosterone; Vas Deferens | 2019 |